S. Galiégue-Zouitina

发表

Adducts from in vivo action of the carcinogen 4-hydroxyaminoquinoline 1-oxide in rats and from in vitro reaction of 4-acetoxyaminoquinoline 1-oxide with DNA and polynucleotides.

S. Galiègue‐Zouitina, B. Bailleul, M. Loucheux‐Lefebvre, 1985, Cancer research.

Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes.

D. Swallow, Y. Kim, J. Gum, 1996, Genomics.

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

B. Quesnel, E. Bertrand, C. Preudhomme, 2012, Blood.

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia

B. Quesnel, E. Bertrand, C. Preudhomme, 2016, Oncotarget.

Repression of the RHOH gene by JunD.

B. Quesnel, C. Shelley, C. Berthon, 2011, The Biochemical journal.

Molecular Basis of 4‐Nitroquinoline 1‐Oxide Carcinogenesis

S. Galiègue‐Zouitina, B. Bailleul, P. Daubersies, 1989, Japanese journal of cancer research : Gann.

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia

B. Quesnel, E. Bertrand, C. Preudhomme, 2013, American journal of hematology.

CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.

B. Quesnel, C. Shelley, X. Troussard, 2015, Cancer research.

Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology

X. Thuru, B. Quesnel, C. André, 2018, BMC Cancer.

Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy

B. Quesnel, C. Shelley, M. Cheok, 2021, EJHaem.